| Literature DB >> 23959593 |
Jeremy S C Clark, Grażyna Adler, Nermin N Salkic, Andrzej Ciechanowicz.
Abstract
UNLABELLED: The allele 1691A F5, conferring Factor V Leiden, is a common risk factor in venous thromboembolism. The frequency distribution for this allele in Western Europe has been well documented; but here data from Central, Eastern and South-Eastern Europe has been included. In order to assess the significance of the collated data, a chi-squared test was applied, and Tukey tests and z-tests with Bonferroni correction were compared.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23959593 PMCID: PMC3825156 DOI: 10.1007/s13353-013-0166-9
Source DB: PubMed Journal: J Appl Genet ISSN: 1234-1983 Impact factor: 3.240
Fig. 1a. Average allele frequencies for 1691A F5 across Europe. b. Significant differences between countries. a. 1691A F5 frequencies: >3 %, <3 % (n.d. = no data). Slavic data (Adler et al. 2012): Poland n = 1588, Czech Republic n = 2819, Slovakia n = 152, Slovenia n = 526, Croatia n = 749, Serbia/Montenegro n = 499; Macedonia n = 130, Bulgaria n = 506, Russia n = 539, Ukraine n = 172, Belarus n = 80; Bosnia/Herzegovina n = 67 (Valjevac et al. 2013). Other data: Group 1: Albania (n = 70; Arsov et al. 2006), Austria (n = 572; Gisslinger et al. 1995, Lalouschek et al. 2005), Finland (n = 1285; Hiltunen et al. 2007), France (n = 1242; Leroyer et al. 1997; Baba-Ahmed et al. 2007; Pasquier et al. 2009), Iceland (n = 96; Rees et al. 1995), Netherlands (n = 2631; Rosendaal et al. 1995; Heijmans et al. 1998; van Dunne et al. 2006), Portugal (n = 303; Ferrer-Antunes et al. 1995; Serrano et al. 2011), Spain (n = 889; Garcia-Gala et al. 1997; Aznar et al. 2000; Frances et al. 2006), Switzerland (n = 100; Redondo et al. 1999). Group 2: Denmark (n = 20242; Larsen et al. 1998; Juul et al. 2002; Benefield et al. 2005), Germany (n = 2199; Aschka et al. 1996; Schambeck et al. 1997; Nabavi et al. 1998; Ehrenforth et al. 1999; Lichy et al. 2006; Toth et al. 2008), Greece (n = 932; Foka et al. 2000; Rees et al. 1995; Lambropoulos et al. 1997; Antoniadi et al. 1999; Ioannou et al. 2000; Aronis et al. 2002; Komitopoulou et al. 2006), Hungary (n = 1196; Tordai et al. 1997; Stankovics et al. 1998; Szolnoki et al. 2001; Shemirani et al. 2011), Italy (n = 226; De Stefano et al. 1999; Sottilotta et al. 2009), Norway (n = 807; Ulvik et al. 1998; Berge et al. 2007), Romania (n = 42; Fischer et al. 2006), Sweden (n = 1343; Svensson et al. 1997; Kjellberg et al. 2010), Turkey (n = 2003; Ozbek and Tangun 1996; Akar et al. 1997; Gurgey and Mesci 1997, Atasay et al. 2003; Agaoglu et al. 2005; Eroglu et al. 2006; Ulukus et al. 2006), U.K. (n = 491; Rees et al. 1995; Catto et al. 1999). b. Significant differences (p < 0.05) between 1691A F5 allele frequency values in European countries, as analyzed by Tukey tests. Capital letters indicate countries with high frequency values significantly different from at least one country; lower case letters indicate which countries had significantly different, and lower, allele frequencies than those with the corresponding capital letter